# Healthspan Capital

Healthspan Capital is a Venture Capital based in El Cerrito, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** El Cerrito, United States
- **Region:** North America
- **Address:** El Cerrito, CA, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.healthspancapital.vc
- **LinkedIn:** https://www.linkedin.com/company/healthspan-capital

## Regulatory record

- **CRD number:** 318727
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/318727

## About

Healthspan Capital is a venture capital firm with a mission to invest in and support longevity biotechnology (LongBio) companies developing therapeutics to extend healthy human lifespan. It invests in early-stage longevity biotech and regenerative medicine startups. The firm believes rejuvenation biotechnology is the future of medicine and operates a rolling fund on AngelList.

## Sectors

- Longevity & AgeTech
- Digital Health
- Biotech

## People

- Nathan Cheng — General Partner
- Sebastian Brunemeier — General Partner
- Michael Chinen — General Partner
- Prof. Matt Kaeberlein — Advisor
- Prof. Claes Wahlestedt — Advisor
- Josef Christensen — Advisor
- Vera Gorbunova — Advisor
- Dan Catron — Advisor
- Michael J. Parnham — Advisor
- Jack Scannell — Advisor
- Boyang Wang — Senior Venture Fellow
- Paolo Binetti — Venture Fellow
- Alexander Tchernev — Venture Fellow
- Colin Maraganore — Venture Fellow
- Ryan Spangler — Venture Fellow
- Nelly Weiser — Venture Fellow

## Questions

### What does Healthspan Capital invest in?

Healthspan Capital invests in early-stage companies developing therapies, diagnostics, and digital health tools that target the biology of aging. Its mandate covers drug discovery platforms aimed at cellular senescence and epigenetic reprogramming, as well as consumer and clinical tools for measuring biological age. The firm focuses on seed and start-up rounds where foundational aging science is being translated for the first time.

### What stages does Healthspan Capital target?

Healthspan Capital deploys at the earliest stages of company formation — seed and start-up — where geroscience discoveries exit academic labs and require initial venture backing. This includes pre-revenue biotech platforms, proof-of-concept diagnostics, and digital health tools that measure hallmarks of aging. The firm does not publicly list later-stage growth equity or public-market mandates.

## Related profiles

- [Health Rosetta Group](https://altss.com/profile/health-rosetta-group)
- [HealthStart](https://altss.com/profile/healthstart)

---

Last updated: 2026-08-11T15:06:57.816Z

Canonical page: https://altss.com/profile/healthspan-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology